Terazosin
- Product NDC
- 68788-4064
- 11-digit product format
- 687884064
- Labeler code
- 68788
- Product ID
- 68788-4064_d1718217-ddab-4a3a-a862-8c952fd5a274
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA075667
- Marketing category
- ANDA
- Marketing start
- 2026-01-28
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Terazosin
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TERAZOSIN HYDROCHLORIDE | 2 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | D32S14F082 |
| Rxcui | 313217 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68788-4064-1 | Terazosin | 100 in 1 BOTTLE | CAPSULE | 100 | | 1 |
| 68788-4064-3 | Terazosin | 30 in 1 BOTTLE | CAPSULE | 30 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 68788-4064-1 | 68788406401 | 100 CAPSULE in 1 BOTTLE (68788-4064-1) | 100 capsule | 2026-01-28 | No | No | Historical |
| 68788-4064-3 | 68788406403 | 30 CAPSULE in 1 BOTTLE (68788-4064-3) | 30 capsule | 2026-01-28 | No | No | Historical |